Wendell David Associates’s Eli Lilly LLY Stock Holding History

Wendell David Associates’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$40.3M	Buy	43,827 +259	+0.6%	+$263K	4.39%	5
2025 Q4	$46.8M	Buy	43,568 +1,419	+3%	+$1.36M	4.76%	5
2025 Q3	$32.2M	Buy	42,149 +494	+1%	+$368K	3.17%	7
2025 Q2	$32.5M	Sell	41,655 -1,270	-3%	-$987K	3.27%	7
2025 Q1	$35.5M	Sell	42,925 -150	-0.3%	-$125K	3.54%	7
2024 Q4	$33.3M	Sell	43,075 -290	-0.7%	-$240K	3.29%	7
2024 Q3	$38.4M	Sell	43,365 -4	-0%	-$3.6K	3.67%	7
2024 Q2	$39.3M	Sell	43,369 -195	-0.4%	-$156K	4%	7
2024 Q1	$33.9M	Buy	43,564 +50	+0.1%	+$35.6K	3.42%	7
2023 Q4	$25.4M	Buy	43,514 +254	+0.6%	+$148K	2.73%	7
2023 Q3	$23.2M	Buy	43,260 +954	+2%	+$492K	2.73%	7
2023 Q2	$19.8M	Buy	42,306 +2,215	+6%	+$929K	2.24%	11
2023 Q1	$13.8M	Hold	40,091	–	–	1.63%	20
2022 Q4	$14.7M	Hold	40,091	–	–	1.8%	17
2022 Q3	$13M	Hold	40,091	–	–	1.74%	20
2022 Q2	$13M	Sell	40,091 -35	-0.1%	-$10.5K	1.65%	23
2022 Q1	$11.5M	Sell	40,126 -120	-0.3%	-$30.9K	1.28%	26
2021 Q4	$11.1M	Sell	40,246 -120	-0.3%	-$30.4K	1.12%	29
2021 Q3	$9.33M	Buy	40,366 +550	+1%	+$136K	1.04%	30
2021 Q2	$9.14M	Sell	39,816 -560	-1%	-$112K	1.02%	31
2021 Q1	$7.54M	Buy	40,376 +267	+0.7%	+$52.2K	0.91%	34
2020 Q4	$6.77M	Buy	40,109 +56	+0.1%	+$8.36K	0.83%	35
2020 Q3	$5.93M	Hold	40,053	–	–	0.79%	36
2020 Q2	$6.58M	Hold	40,053	–	–	0.95%	34
2020 Q1	$5.56M	Hold	40,053	–	–	0.94%	33
2019 Q4	$5.26M	Hold	40,053	–	–	0.73%	40
2019 Q3	$4.48M	Sell	40,053 -200	-0.5%	-$22.3K	0.66%	43
2019 Q2	$4.46M	Hold	40,253	–	–	0.67%	41
2019 Q1	$5.22M	Buy	40,253 +36	+0.1%	+$4.38K	0.81%	37
2018 Q4	$4.65M	Sell	40,217 -316	-0.8%	-$35.3K	0.84%	37
2018 Q3	$4.35M	Hold	40,533	–	–	0.68%	42
2018 Q2	$3.46M	Buy	40,533 +1,635	+4%	+$134K	0.59%	46
2018 Q1	$3.01M	Buy	38,898 +166	+0.4%	+$13.4K	0.54%	47
2017 Q4	$3.27M	Sell	38,732 -1,600	-4%	-$136K	0.56%	45
2017 Q3	$3.45M	Sell	40,332 -434	-1%	-$35.6K	0.61%	41
2017 Q2	$3.35M	Buy	40,766 +16	+0%	+$1.3K	0.63%	40
2017 Q1	$3.43M	Sell	40,750 -600	-1%	-$48.1K	0.66%	42
2016 Q4	$3.04M	Hold	41,350	–	–	0.6%	46
2016 Q3	$3.32M	Hold	41,350	–	–	0.65%	45
2016 Q2	$3.27M	Sell	41,350 -400	-1%	-$30.1K	0.64%	47
2016 Q1	$3.01M	Hold	41,750	–	–	0.58%	47
2015 Q4	$3.51M	Hold	41,750	–	–	0.69%	42
2015 Q3	$3.51M	Hold	41,750	–	–	0.72%	41
2015 Q2	$3.46M	Hold	41,750	–	–	0.67%	42
2015 Q1	$3.05M	Hold	41,750	–	–	0.59%	45
2014 Q4	$2.88M	Hold	41,750	–	–	0.56%	48
2014 Q3	$2.71M	Buy	41,750 +200	+0.5%	+$12.7K	0.57%	49
2014 Q2	$2.58M	Sell	41,550 -200	-0.5%	-$11.9K	0.54%	51
2014 Q1	$2.46M	Sell	41,750 -1,650	-4%	-$92.1K	0.54%	51
2013 Q4	$2.21M	Sell	43,400 -468	-1%	-$23.4K	0.49%	52
2013 Q3	$2.19M	Buy	43,868 +188	+0.4%	+$9.84K	0.53%	51
2013 Q2	$2.14M	Buy	+43,680	New	+$2.38M	0.53%	50

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wendell David Associates's LLY Position: Q1 2026 in Review

Wendell David Associates increased its Eli Lilly (LLY) stake by 0.59% in Q1 2026, buying an estimated $263K and bringing the position to 43,827 shares worth $40.3M. The position accounts for 4.39% of the portfolio, ranked #5.

Wendell David Associates first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $46.8M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Wendell David Associates held 43,827 shares of Eli Lilly worth $40.3M as of Q1 2026.
Wendell David Associates bought 259 Eli Lilly shares in Q1 2026, an estimated $263K.
Eli Lilly made up 4.39% of Wendell David Associates's portfolio in Q1 2026, its #5 holding.
Wendell David Associates first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
Wendell David Associates's Eli Lilly position peaked at $46.8M in Q4 2025.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Wendell David Associates's 13F filing for Q1 2026, filed 23 Apr 2026.